Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The coronavirus pandemic has shone a light on both immunology as a whole and China’s work in the field, as it and other countries race to develop a vaccine to bring the world out of lockdown. Here, Nature speaks to scientists and policymakers about China’s response to the pandemic, and what comes next for the country’s immunology researchers.
By promoting basic life sciences research, a medical biology institute in China has accelerated the development and clinical use of vaccines, offering protection against diseases.
An academic society in Shanghai has inspired a network of leading immunologists whose cross-disciplinary work enables new diagnostics and therapeutics for immune disorders and other diseases.